Use of Cetuximab for Unresectable or Metastatic Esophageal and Gastric Cancer
Clinical trial NCT00130689 · COMPLETED
Trial details
- NCT number
- NCT00130689
- Sponsor
- Dana-Farber Cancer Institute
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-07-01
- Primary completion
- 2010-09-01
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.